global view constructed of white lines


Preparing for Ketamine-assisted therapy
April 10, 2024

Preparing for Ketamine-Assisted Psychotherapy

by Zara Jethani

Preparation for ketamine-assisted psychotherapy (KAP) involves several key components aimed at ensuring the safety and efficacy of the treatment, as well as preparing the patient mentally and emotionally for the experience. Keep reading.

A patient guide to Ketamine-Assisted Therapy
March 27, 2024

A New Patient’s Guide to Ketamine-Assisted Psychotherapy

by Zara Jethani

In recent years, ketamine-assisted psychotherapy (KAP) has emerged as a promising treatment for various mental health conditions, offering new hope to individuals who have not found relief through conventional therapies. Learn more.

An Early Sign of Alzheimer’s Disease May Be Lurking in Your Gut, Study Finds blog feature image
February 28, 2024

An Early Sign of Alzheimer’s Disease May Be Lurking in Your Gut, Study Finds

by Brianna Rauchman

New research found a connection between the gut microbiome and Alzheimer's disease. Dr. David Merrill offers his insights on these findings.

Your Guide to Integration & Ketamine Therapy blog feature image
January 16, 2024

Maximizing the Benefits of Ketamine Therapy through Integration

by Brianna Rauchman

Ketamine-assisted psychotherapy (KAP) is emerging as a significant therapeutic approach for various mental health conditions. However, the efficacy of KAP is greatly enhanced when coupled with a crucial component: integration. Learn how Pacific Neuroscience Institute® (PNI®)'s Treatment & Research in Psychedelics (TRIP) Center uses integration to optimize patient outcomes.

Unveiling the Benefits of Ketamine-Assisted Psychotherapy Blog Feature Image
December 5, 2023

Unveiling the Benefits of Ketamine-Assisted Psychotherapy

by PNI Experts

Explore the transformative benefits of ketamine therapy in treating treatment-resistant depression, anxiety disorders, PTSD, chronic pain, and addiction. Learn how Pacific Neuroscience Institute's expert team harnesses the potential of ketamine to offer hope and relief.

Demi Lovato Opens Up About Mental Health
September 26, 2023

Why Demi Lovato Was ‘Relieved’ After Being Diagnosed with Bipolar Disorder

by Guest Author

Discover Demi Lovato's journey with bipolar disorder, with expert insight from David Merrill, MD, PhD, director of the Pacific Brain Health Center. Learn why celebrities like her sharing their mental health challenges is essential to destigmatize conditions and encourage seeking help. Explore the importance of proper diagnosis and treatment for mental health conditions. Join the conversation about breaking the stigma surrounding mental health.

Nature-Themed Psychedelic Therapy For Alcohol Addiction blog feature image
September 22, 2023

Nature-Themed Psychedelic Therapy for Alcohol Addiction: Promising Findings Using Renowned Filmmaker’s Videos

by Guest Author

Immersive nature videos may enhance psychedelic-assisted therapy for alcohol addiction, according to research by Pacific Neuroscience Institute and renowned filmmaker Louie Schwartzberg.

Pacific TRIP Center of Excellence
August 7, 2023

Embracing the Psychedelic Renaissance: Pacific Neuroscience Institute Unveils New Center of Excellence

by PNI Experts

We are excited to announce the expansion of our psychedelics program into a new center of excellence: The Pacific Treatment & Research in Psychedelics (TRIP). As a leader in psychedelic research, Pacific Neuroscience Institute (PNI) continues to pioneer innovative mental health solutions.

July 6, 2023

UFC Fighter’s Brain Injury Successfully Treated with Psychedelic Therapy

by Brianna Rauchman

Discover the transformative power of psychedelics for treating traumatic brain injuries (TBI) and mental health conditions. Witness former UFC fighter Ian McCall's inspiring recovery using psilocybin mushrooms. Join the conversation on revolutionizing mental health treatment with Daniel F. Kelly, MD, CEO of Pacific Neuroscience Institute (PNI) and board-certified neurosurgeon.

June 21, 2023

Magic Mushrooms: Pushing Frontiers in Mental Health Dr. Keith Heinzerling & Dr. Daniel Kelly On “Your Daily Dose with Kym Douglas”

by Anthony Effinger

This episode comes from the Saint John’s Health Center Foundation’s podcast, Your Daily Dose with Kym Douglas. Pacific Neuroscience Institute experts, Dr. Keith Heinzerling and Dr. Daniel Kelly discuss the Treatment & Research in Psychedelics (TRIP) program at PNI. Dr. Heinzerling, an addiction medicine specialist and TRIP director, and Dr. Kelly, director and one of the four founders of PNI describe how psychedelic-assisted therapy with compounds such as psilocybin from “magic mushrooms” in clinical trials can help treat conditions such as alcohol use disorder, anxiety, and depression. Listen to this episode to learn how these doctors envision psychedelic-assisted therapy transforming the current model of mental health care.

Last updated: August 31st, 2023